STAG3
protein-codingstromal antigen 3, the group of Armadillo like helical domain containing|Cohesin complex
Gene summary
The protein encoded by this gene is expressed in the nucleus and is a subunit of the cohesin complex which regulates the cohesion of sister chromatids during cell division. A mutation in this gene is associated with premature ovarian failure. Alternate splicing results in multiple transcript variants encoding distinct isoforms. This gene has multiple pseudogenes. [provided by RefSeq, Apr 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~36.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0030507
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014321
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0030507
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014321
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Endocrine; Genitourinary; Obstetric
Intervention: Obstetric
Rationale: Genetic knowledge may be beneficial to allow interventions such as preserving eggs in women with premature ovarian insufficiency
Comments: One described individual was reported as additionally affected by ovarian cancer
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to STAG3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001282717.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 15 | 18 | |||
| missense | 2 | 153 | 14 | 169 | ||
| nonsense | 4 | 5 | 9 | |||
| start loss | 0 | |||||
| frameshift | 6 | 7 | 13 | |||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 7 | 11 | ||
| Total | 11 | 17 | 163 | 29 | 0 | 220 |
Highest pathogenic variant AF is 0.000124558
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001269646.1 | 33 | MANE Select | |
| Ensembl | ENSP00000477973.1 | 33 | MANE Select | |
| RefSeq | NP_001269645.1 | 33 | Standard | |
| RefSeq | NP_001269647.1 | 31 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Oocyte meiosis - Homo sapiens (human)
- Reproduction
- Meiotic synapsis
- Meiosis
- Cell Cycle
Biological Process
- sister chromatid cohesion
- synaptonemal complex assembly
Molecular Function
- chromatin binding
Cellular Component
- chromosome, centromeric region
- chromatin
- synaptonemal complex
- extracellular space
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000426455
- Coding exons
- 33
- Length
- 43926
- Individuals with no LoFs
- 125614
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 134
- Defined
- 125748
- p
- 0.000533
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.66 | 569 | 692 | 0.823 | 0.0000403 | 8033 |
| Missense (PolyPhen) | 123 | 177.26 | 0.69388 | 2040 | ||
| Synonymous | 1.08 | 253 | 276 | 0.917 | 0.0000159 | 2388 |
| Loss of Function | 4.32 | 33 | 72.8 | 0.453 | 0.00000379 | 819 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00068 | 0.00068 | rare |
| Latino/Admixed American | 0.00035 | 0.00035 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00064 | 0.00064 | rare |
| South Asian | 0.00076 | 0.00075 | rare |
| Other | 0.00098 | 0.00098 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Meiosis specific component of cohesin complex. The cohesin complex is required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The meiosis- specific cohesin complex probably replaces mitosis specific cohesin complex when it dissociates from chromatin during prophase I. {ECO:0000250|UniProtKB:O70576}.;
- Disease
- DISEASE: Premature ovarian failure 8 (POF8) [MIM:615723]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:24597867, ECO:0000303|PubMed:22428046}. Note=The disease is caused by mutations affecting the gene represented in this entry. A homozygous deletion in STAG3 predicted to result in frameshift and premature truncation, has been shown to be the cause of premature ovarian failure in a large consanguineous family. {ECO:0000269|PubMed:24597867}.;
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- LoFtool
- 0.921
- RVIS EVS
- -1.1
- RVIS percentile EVS
- 6.91
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.680
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |